Evaluation of Recombinant Adenovirus Vaccines Based on Glycoprotein D and Truncated UL25 Against Herpes Simplex Virus Type 2 in Mice
Microbiology and Immunology - United States
doi 10.1111/1348-0421.12482
Full Text
Open PDFAbstract
Available in full text
Date
May 1, 2017
Authors
Publisher
Wiley